000			01587nam a2200361 a 4500
001			EBC851166
003			MiAaPQ
005			20240120133217.0
006			m o d |
007			cr cn|||||||||
008			120309s2012 gw a sb 001 0 eng d
020			_z9783527328499
020			_a9783527644797 (electronic bk.)
035			_a(MiAaPQ)EBC851166
035			_a(Au-PeEL)EBL851166
035			_a(CaPaEBR)ebr10531468
035			_a(CaONFJC)MIL345422
035			_a(OCoLC)775871780
040			_aMiAaPQ _cMiAaPQ _dMiAaPQ
050		4	_aRS431.P75 _bT44 2012
245	0	0	_aTherapeutic proteins _h[electronic resource] : _bstrategies to modulate their plasma half-lives / _cedited by Roland Kontermann.
260			_aWeinheim, Germany : _bWiley-Blackwell, _c2012.
300			_axviii, 354 p. : _bill.
504			_aIncludes bibliographical references and index.
505	0		_apt. 1. General information -- pt. 2. Half-life extension through chemical and post-translational modifications -- pt. 3. Half-life modulation involving recycling by the neonatal Fc receptor -- pt. 4. Half-life extension with pharmaceutical formulations.
533			_aElectronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650		0	_aProtein drugs _xDesign.
650		0	_aProteins _xTherapeutic use.
655		4	_aElectronic books.
700	1		_aKontermann, Roland.
710	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=851166 _zClick to View
999			_c74572 _d74572